HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joseph Dosch Selected Research

Cytokines

9/2017Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joseph Dosch Research Topics

Disease

4Neoplasms (Cancer)
09/2017 - 12/2011
2Neoplasm Metastasis (Metastasis)
08/2015 - 06/2008
1Colorectal Neoplasms (Colorectal Cancer)
09/2017
1Pancreatic Neoplasms (Pancreatic Cancer)
06/2008

Drug/Important Bio-Agent (IBA)

1Metalloproteases (Metalloproteinases)IBA
09/2017
1EnzymesIBA
09/2017
1Membrane Proteins (Integral Membrane Proteins)IBA
09/2017
1CytokinesIBA
09/2017
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2017
1DisintegrinsIBA
09/2017
1Phosphotransferases (Kinase)IBA
01/2015
1GemcitabineFDA Link
12/2011
1Epithelial Cell Adhesion MoleculeIBA
06/2008
1Biological ProductsIBA
06/2008

Therapy/Procedure

1Therapeutics
08/2015
1Drug Therapy (Chemotherapy)
08/2015